-+ 0.00%
-+ 0.00%
-+ 0.00%

EYEPOINT - DURAVYU ACHIEVES 42% REDUCTION IN TREATMENT BURDEN VS AFLIBERCEPT

路透·08/17/2026 11:00:01

登录查看新闻详情